Stock listing

gettex:4DX Pluri Inc. Aktie

German listing (gettex) of Pluri Inc. · home listing NASDAQ:PLUR

Follow Pluri Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:PLUR

$0.94 USD +0.02 (+2.7%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:PLUR

Past year -75.9% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.90 – $1.06 USDNov 20, 2026
Volume
25,866 sharesNov 20, 2026
Market cap
$11.85M USDAt the close on Nov 20, 2026 · price × 12.61M shares outstanding
52-week range
$0.85 – $3.99 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$43,140 USDMedian day 16,700 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Pluri Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:PLUR · Home$0.94 USD+0.025 (+2.7%)25,866$0.975$1.064$0.90$0.915Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:PLUR · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.94+0.025+2.7%$0.975$1.064$0.9025,866
$0.915-0.065-6.6%$0.999$0.999$0.90334,973
$0.98-0.06-5.8%$1.04$1.04$0.9425,600
$1.04-0.01-1.0%$1.05$1.09$1.0123,700
$1.05-0.04-3.7%$1.17$1.17$1.0414,552
$1.09-0.11-9.2%$1.17$1.19$1.08214,893
$1.20+0.08+7.1%$1.26$1.26$1.0824,529
$1.12-0.06-5.1%$1.19$1.19$1.08816,168
$1.18-0.055-4.5%$1.24$1.255$1.0641,222
$1.235+0.045+3.8%$1.19$1.235$1.1822,707
$1.19-0.04-3.3%$1.21$1.21$1.0427,598
$1.23-0.04-3.1%$1.27$1.27$1.20216,857
$1.27+0.07+5.8%$1.30$1.31$1.1849,394
$1.20-0.04-3.2%$1.28$1.30$1.2098,937
$1.24+0.04+3.3%$1.305$1.305$1.2029,334
$1.20-0.03-2.4%$1.255$1.34$1.1837,394
$1.23+0.04+3.4%$1.20$1.40$1.19223,457
$1.19+0.07+6.2%$1.22$1.29$1.15132,774
$1.12+0.13+13.1%$1.18$1.35$0.96485,018
$0.99-0.02-2.0%$1.06$1.24$0.9770,100
$1.01-0.04-3.8%$1.06$1.07$1.019,600
$1.05+0.15+16.7%$1.00$1.08$0.9150,100
$0.90+0.05+5.9%$0.89$0.95$0.8912,500
$0.85-0.08-8.6%$0.90$0.96$0.858,000
$0.93-0.01-1.1%$0.99$0.99$0.939,100
$0.94+0.01+1.1%$0.93$0.96$0.932,000
$0.93-0.01-1.1%$0.95$0.95$0.934,800
$0.94-0.03-3.1%$0.96$0.96$0.9114,900
$0.97+0.02+2.1%$0.91$0.98$0.877,700
$0.95-0.05-5.0%$0.97$0.97$0.851,500
$1.00-0.04-3.8%$1.01$1.01$0.996,100
$1.04+0.05+5.1%$0.98$1.04$0.8561,500
$0.99-0.05-4.8%$1.05$1.07$0.986,100
$1.04+0.03+3.0%$1.01$1.06$1.006,000
$1.01-0.02-1.9%$1.04$1.06$1.0110,600
$1.03+0.03+3.0%$1.00$1.07$1.0010,400
$1.00-0.01-1.0%$1.01$1.01$0.9637,300
$1.01+0.04+4.1%$0.97$1.04$0.9714,600
$0.97-0.04-4.0%$1.02$1.09$0.9016,700
$1.01-0.04-3.8%$1.13$1.16$1.015,100
$1.05-0.01-0.9%$1.04$1.11$0.9814,500
$1.06-0.04-3.6%$1.08$1.08$1.0114,800
$1.10+0.03+2.8%$1.06$1.14$1.0031,800
$1.07-0.01-0.9%$1.08$1.15$1.018,300
$1.080.000.0%$1.08$1.16$1.0223,800
$1.08-0.06-5.3%$1.06$1.14$1.0641,600
$1.14-0.03-2.6%$1.19$1.29$1.1030,800
$1.17-0.07-5.6%$1.26$1.31$1.1412,900
$1.24+0.06+5.1%$1.19$1.36$1.197,000
$1.18-0.07-5.6%$1.23$1.31$1.189,600
$1.25-0.12-8.8%$1.34$1.34$1.2425,400
$1.37+0.10+7.9%$1.26$1.39$1.257,400
$1.27-0.09-6.6%$1.36$1.40$1.2717,600
$1.36-0.01-0.7%$1.41$1.45$1.3115,500
$1.37-0.05-3.5%$1.44$1.45$1.2513,600
$1.42-0.04-2.7%$1.51$1.52$1.3837,700
$1.46-0.01-0.7%$1.44$1.46$1.443,700
$1.47-0.06-3.9%$1.53$1.57$1.4148,900
$1.530.000.0%$1.52$1.63$1.4624,300
$1.53+0.05+3.4%$1.51$1.64$1.45100,500
$1.48-0.18-10.8%$1.63$1.63$1.4896,500
$1.66+0.10+6.4%$1.57$1.67$1.5719,000
$1.56-0.15-8.8%$1.68$1.71$1.5538,200
$1.71-0.06-3.4%$1.70$1.84$1.704,600
$1.77+0.01+0.6%$1.75$1.77$1.7215,200

Splits

3 splits since 2007 · NASDAQ:PLUR · every price before a split is adjusted for it

DayRatioWhat
1-for-8Consolidation
1-for-10Consolidation
1-for-200Consolidation
Ticker
gettex:4DX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
gettex
Currency
EUR

What changed lately

Latest news

All Pluri Inc. news

Pluri Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
16 in the last 12 months · 51 in all · newest Nov 16, 2026 · oldest 2019
Decks
21 decks · latest Oct 29, 2026

Where Pluri Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:PLUR · Home listingNASDAQUnited StatesUSD
TASE:PLURTASEIsraelILA
gettex:4DX · This pagegettexGermanyEUR
Frankfurt:4DXFrankfurtGermanyEUR
BOATS:PLURBOATSUnited StatesUSD
Lang & Schwarz:A408KWLang & SchwarzGermanyEUR
Munich:4DXMunichGermanyEUR

Valuation

EV/sales 26.5× against a median of 4.8×: 4th lowest of 6 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$38.65M USD
P/E
Loss
EV/sales
26.5×
EV/EBITDA
Negative EBITDA
Price/book
Negative equity
Gross margin
51.9%
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
Negative equity
Beta vs S&P 500
0.53

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Pluri Inc. · NASDAQ:PLURUS$11.85MUS$38.65Mn/a26.5×n/an/an/an/a0.53
MIRA Pharmaceuticals, Inc. · NASDAQ:MIRAUS$12.23MUS$5.26Mn/an/an/a1.8×n/a0.0×1.48
Genflow Biosciences PLC · LSE:GENFUS$12.06MUS$11.23Mn/an/an/a48.5×n/a0.0×n/a
Xintela AB · OMXSTO:XINTUS$11.89MUS$11.82Mn/a39.8×n/an/an/an/an/a
BioCardia, Inc. · NASDAQ:BCDAUS$11.88MUS$10.22Mn/an/an/a14.2×n/a0.7×0.42
Synlogic Inc · OTC:SYBXUS$11.76MUS$201,442n/an/an/a1.2×n/a0.0×0.50
Imugene Ltd · ASX:IMUUS$11.74MUS$14.16Mn/an/an/a2.0×n/a0.7×n/a
Radiopharm Theranostics Limited · ASX:RADUS$11.59MUS$8.85Mn/a4.8×n/a0.7×n/a0.0×n/a
Simris Group AB Class B · OMXSTO:SIMRIS_BUS$11.55MUS$19.55Mn/a144×n/a154×n/a117×n/a
Aelis Farma SA · EURONEXT:AELISUS$11.55MUS$9.09Mn/a4.0×n/a4.5×−308.7%1.9×n/a
Dyadic International, Inc. · NASDAQ:DYAIUS$11.51MUS$12.03Mn/a3.9×n/an/a−226.9%n/a1.12
Median of the othersUS$11.75MUS$10.73M4.8×3.3×−267.8%0.3×0.81

Forecasts

Analysts' consensus from EODHD, read Nov 14, 2026. Not 6ix's view and not investment advice.

Price target
12.00 USD · Analysts' mean
EPS, year to Jun 2026
-2.70 · 1 analyst

Team and board

Officers

OfficerRole
Katty DoweryCEO of CellaV Health & Aesthetics
Yaky YanayCEO & President
Liat ZaltsChief Financial Officer
Nofar Glaich-DabachVP Human Resources
Ori ShalemVP Operations and Manufacturing
Efrat KaduriChief Business Development Officer – Pharma
Lior RavivChief Technology Officer
Nimrod Bar ZviChief Commercial Officer

Board

DirectorRole
Alejandro WeinsteinChairman of the Board, Board Member
Doron ShorrerBoard Member
Maital Shemesh-RasmussenBoard Member
Rami LeviBoard Member

Events

QuarterResultsShare move
Q1 2027Nov 12, 2026−12.5%
Q4 2026Sep 16, 2026−7.7%
Q1 2026Nov 12, 2025 · After close−6.1%
Q4 2025Sep 17, 2025 · After close−4.3%
Q3 2025May 7, 2025 · After close+6.9%
Q2 2025Feb 10, 2025 · After close+0.7%
Q1 2025Nov 11, 2024 · After close+8.4%
Q4 2024Sep 10, 2024 · After close−0.8%
Q3 2024May 9, 2024 · After close−2.4%
Q2 2024Feb 12, 2024 · After close−7.5%
All 20 quarters
QuarterResultsShare move
Q1 2024Nov 13, 2023 · After close−1.8%
Q4 2023Sep 12, 2023 · After close−1.6%
Q3 2023May 9, 2023 · After close0.0%
Q2 2023Feb 13, 2023 · After close−1.6%
Q1 2023Nov 10, 2022 · After close+9.7%
Q4 2022Sep 21, 2022 · After close+1.3%
Q3 2022May 9, 2022 · After close+3.7%
Q2 2022Feb 7, 2022 · After close+1.1%
Quarter to Sep 30, 2021Nov 8, 2021 · After close+9.2%
Quarter to Jun 30, 2021Sep 13, 2021 · After close−2.7%

Open Events

Decks

DeckKindSlidesDate
Corporate Update (October 2026)Corporate update24 slidesOct 29, 2026
Investor Presentation (October 2026)Investor deck18 slidesOctober 2026
Investor Presentation (April 2026)Investor deck20 slidesApril 2026
Investor Presentation (March 2026)Investor deck22 slidesMarch 2026
Investor Presentation (January 2026)Investor deck27 slidesJanuary 2026
Investor Presentation (November 2025)Investor deck25 slidesNovember 2025
Investor Presentation (September 2025)Investor deck26 slidesSeptember 2025
Investor Presentation (July 2025)Investor deck25 slidesJuly 2025
Investor Presentation (May 2025)Investor deck25 slidesMay 2025
Investor Presentation (April 2025)Investor deck26 slidesApr 1, 2025
All 21 decks
DeckKindSlidesDate
Investor Presentation (April 2025)Investor deck25 slidesApril 2025
Investor Presentation (April 2025)Investor deck24 slidesApril 2025
Investor Presentation (March 2025)Investor deck26 slidesMarch 2025
Investor Presentation (February 2025)Investor deck26 slidesFebruary 2025
Investor Presentation (December 2024)Investor deck29 slidesDecember 2024
Investor Presentation (September 2024)Investor deck29 slidesSeptember 2024
Investor Presentation (May 2024)Investor deck35 slidesMay 2024
Pluristem Therapeutics — Corporate Update (May 2021)Corporate update20 slidesMay 3, 2021
Pluristem Therapeutics — Corporate Update (December 2020)Corporate update15 slidesDec 9, 2020
Pluristem Therapeutics — IPO Roadshow (October 2017)IPO roadshow43 slidesOct 30, 2017
Pluristem Therapeutics — Investor Presentation (May 2015)Investor deck44 slidesMay 27, 2015

Open Decks

Financings

RaiseDate
Registered direct offering of common shares (or common share equivalents) with concurrent private placement of warrants
Announced: about US$3.3M · US$1.5 a share · ½ warrant at US$1.65 for 66 months · A.G.P./Alliance Global Partners
Dealers: A.G.P./Alliance Global Partners (lead)
Use of proceeds: Working capital and other general corporate purposes
Aug 27, 2026
Private placement of common shares and warrants
Announced: about US$2.5M · US$4 a share · Warrants at US$4.25
Buyers: entity beneficially owned by Mr. Weinstein (625,000 common shares and warrants for up to 625,000 additional shares)
Insiders: The investor is an entity beneficially owned by Alejandro Weinstein, newly appointed Chairman and one of the largest shareholders
Use of proceeds: General working capital
Dec 9, 2025
Private placement of common shares and warrants
Announced: US$3.5M · US$4.61 a share · Warrants at US$5.568
Buyers: Merchant Adventure Fund, L.P. ($3.5 million; 759,219 common shares and warrants to purchase up to 45,553 common shares)
Use of proceeds: Support the company's growth in cell-based technology and expansion across pharma, foodtech and agtech
Feb 4, 2025
Strategic investment of common shares, common warrants and pre-funded warrants
Announced: US$6.5M · US$4.61 a share · Warrants at US$5.568 for 36 months
Buyers: Alejandro Weinstein (Leads the $6.5 million investment through a wholly-owned company; will join the Board of Directors)
Use of proceeds: Working capital and general corporate purposes
Jan 23, 2025

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue1.02M1.34M326.0K287.0K234.0K023.0K54.0K50.0K
Cost of revenue563.0K682.0K4.00K9.00K1.05M1.37M1.57M2.00K2.00K2.18M
Gross profit453.0K654.0K322.0K278.0K234.0K-1.37M23.0K52.0K48.0K-2.18M
Research and development15.1M12.9M12.4M15.7M24.6M30.5M23.1M29.9M26.4M24.0M
Selling, general and administrative10.3M9.98M10.0M11.8M17.4M20.6M7.92M9.16M11.2M6.93M
Operating income-24.9M-22.2M-22.2M-27.2M-41.6M-50.6M-29.5M-35.5M-33.7M-28.0M
Depreciation and amortization511.0K316.0K253.0K362.0K1.05M1.37M1.57M1.96M2.02M2.18M
EBITDA-24.4M-21.9M-21.9M-26.9M-40.5M-49.3M-27.9M-33.6M-31.7M-25.8M
Interest expense932.0K873.0K866.0K843.0K887.0K78.0K196.0K29.0K937.0K
Income before tax-25.4M-23.3M-21.3M-28.9M-41.4M-49.9M-29.2M-35.3M-26.1M-27.8M
Income tax-25.0K-5.00K410.0K277.0K-351.0K78.0K196.0K-94.0K7.61M-205.0K
Net income-23.8M-22.6M-20.9M-28.3M-41.2M-49.9M-29.2M-35.3M-26.1M-27.8M
Earnings per share, basic-2.44-3.56-3.99-6.24-1.28-1.77-1.60-2.90-2.50-3.20
Earnings per share, diluted-2.44-3.56-3.99-6.24-1.28-1.77-1.60-2.90-2.50-3.20

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents3.53M5.89M6.78M5.36M9.77M31.2M8.27M4.11M8.82M4.71M
Short-term investments4.28M14.7M23.2M34.8M45.2M33.7M37.5M19.6M21.1M6.24M
Receivables219.0K722.0K638.0K527.0K3.00K19.0K1.61M1.42M58.0K1.04M
Inventory222.0K269.0K597.0K555.0K692.0K
Current assets8.73M22.1M31.1M41.4M57.7M67.4M48.5M26.4M32.0M29.0M
Property, plant and equipment1.57M1.82M688.0K688.0K739.0K1.50M2.52M3.84M5.68M7.28M
Goodwill3.14M3.14M0
Total assets24.9M38.7M39.5M50.8M68.1M93.5M65.5M31.3M39.0M37.5M
Accounts payable702.0K866.0K964.0K1.81M1.78M2.53M1.97M2.28M3.26M1.97M
Current liabilities32.7M32.3M4.45M5.62M6.83M11.5M7.99M8.16M8.55M5.41M
Long-term debt24.0M23.5M21.7M23.9M1.26M
Total debt34.9M34.0M29.6M29.9M28.8M24.6M1.58M
Total liabilities42.3M39.5M34.1M35.5M35.9M36.4M9.43M9.49M10.5M7.28M
Shareholders' equity-23.0M-6.84M96.0K13.4M30.0M57.2M56.1M21.8M28.5M30.3M
Shares outstanding10.8M7.89M5.41M5.16M32.5M32.0M25.5M15.1M11.4M96.9M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations-19.6M-18.2M-18.0M-22.9M-36.5M-30.9M-26.4M-29.5M-21.4M-21.6M
Capital spending-633.0K-1.62M-323.0K-262.0K-280.0K-373.0K-270.0K-239.0K-342.0K-378.0K
Free cash flow-20.2M-19.8M-18.3M-23.1M-36.8M-31.3M-26.6M-29.7M-21.7M-22.0M
Cash from investing9.90M8.03M10.6M9.70M11.8M-7.26M-30.5M1.17M5.68M4.36M
Cash from financing7.04M9.53M8.84M8.02M7.50M61.4M60.9M23.6M19.9M15.8M
Change in cash-2.62M-475.0K1.42M-5.16M-20.4M22.6M4.04M-4.70M4.11M-1.52M

Open Financials

Filings

FilingDateTypeFiled with
SCHEDULE 13G · Big-stake noticeNov 16, 2026Big-stake noticeSEC
S-3/A · Registration statement, amendedNov 12, 2026Offer documentSEC
10-Q · Quarterly reportNov 12, 2026Quarterly reportSEC
8-K · Current reportOct 30, 2026Material contractSEC
SCHEDULE 13D/A · Big-stake notice, amendedOct 27, 2026Big-stake noticeSEC
4 · Change in ownershipOct 27, 2026Insider tradeSEC
8-K · Current reportOct 20, 2026Material contractSEC
EFFECT · Notice that a registration is effectiveOct 16, 2026Other filingsSEC
S-1 · Registration statementOct 6, 2026Offer documentSEC
S-3 · Registration statementSep 10, 2026Offer documentSEC
Show 200 filings
FilingDateTypeFiled with
S-8 · Registration statement for employee plansSep 10, 2026Offer documentSEC
S-8 · Registration statement for employee plansSep 10, 2026Offer documentSEC
10-K · Annual reportSep 10, 2026Annual reportSEC
DSep 4, 2026Other filingsSEC
424B5 · ProspectusAug 28, 2026Offer documentSEC
8-K · Current reportAug 28, 2026Material contractSEC
424B3 · ProspectusAug 26, 2026Offer documentSEC
4 · Change in ownershipAug 24, 2026Insider tradeSEC
4 · Change in ownershipAug 24, 2026Insider tradeSEC
8-K · Current reportAug 17, 2026Current reportSEC
8-K · Current reportJul 14, 2026Current reportSEC
8-K · Current reportJul 13, 2026Current reportSEC
3 · Initial statement of ownershipJul 7, 2026Insider tradeSEC
4 · Change in ownershipJul 1, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJul 1, 2026Big-stake noticeSEC
8-K · Current reportJun 22, 2026Material contractSEC
8-K · Current reportJun 1, 2026Current reportSEC
10-Q · Quarterly reportMay 14, 2026Quarterly reportSEC
4 · Change in ownershipMay 4, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedMay 1, 2026Big-stake noticeSEC
ARS · Annual report to shareholdersApr 23, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 23, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 23, 2026Meeting noticeSEC
8-K · Current reportMar 27, 2026Material contractSEC
8-K · Current reportMar 2, 2026Current reportSEC
10-Q · Quarterly reportFeb 12, 2026Quarterly reportSEC
8-K · Current reportJan 22, 2026Current reportSEC
4 · Change in ownershipJan 5, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJan 5, 2026Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedDec 15, 2025Big-stake noticeSEC
8-K · Current reportDec 9, 2025Material contractSEC
4 · Change in ownershipDec 8, 2025Insider tradeSEC
4 · Change in ownershipDec 8, 2025Insider tradeSEC
4 · Change in ownershipDec 8, 2025Insider tradeSEC
4 · Change in ownershipDec 8, 2025Insider tradeSEC
4 · Change in ownershipDec 8, 2025Insider tradeSEC
4 · Change in ownershipDec 8, 2025Insider tradeSEC
4 · Change in ownershipDec 8, 2025Insider tradeSEC
4 · Change in ownershipNov 20, 2025Insider tradeSEC
4 · Change in ownershipNov 13, 2025Insider tradeSEC
10-Q · Quarterly reportNov 12, 2025Quarterly reportSEC
4 · Change in ownershipOct 16, 2025Insider tradeSEC
8-K · Current reportOct 16, 2025Management or board changeSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 14, 2025Big-stake noticeSEC
EFFECT · Notice that a registration is effectiveSep 26, 2025Other filingsSEC
CORRESP · Letter to the SECSep 23, 2025Other filingsSEC
3 · Initial statement of ownershipSep 22, 2025Insider tradeSEC
UPLOAD · Letter from the SECSep 22, 2025Other filingsSEC
S-3 · Registration statementSep 17, 2025Offer documentSEC
S-8 · Registration statement for employee plansSep 17, 2025Offer documentSEC
S-8 · Registration statement for employee plansSep 17, 2025Offer documentSEC
10-K · Annual reportSep 17, 2025Annual reportSEC
8-K · Current reportSep 12, 2025Current reportSEC
8-K · Current reportSep 11, 2025Management or board changeSEC
8-K · Current reportJul 3, 2025Management or board changeSEC
4 · Change in ownershipJul 1, 2025Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJun 9, 2025Big-stake noticeSEC
UPLOAD · Letter from the SECMay 28, 2025Other filingsSEC
ARS · Annual report to shareholdersMay 27, 2025Annual reportSEC
DEF 14A · Proxy statementMay 27, 2025Meeting noticeSEC
8-K · Current reportMay 27, 2025Current reportSEC
CORRESP · Letter to the SECMay 21, 2025Other filingsSEC
SCHEDULE 13D/A · Big-stake notice, amendedMay 20, 2025Big-stake noticeSEC
10-Q · Quarterly reportMay 13, 2025Quarterly reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedMay 12, 2025Big-stake noticeSEC
8-K · Current reportMay 8, 2025Current reportSEC
8-K · Current reportApr 29, 2025Current reportSEC
PRE 14A · Preliminary proxy statementApr 28, 2025Meeting noticeSEC
8-K · Current reportApr 28, 2025Current reportSEC
8-K · Current reportApr 25, 2025Material contractSEC
8-K · Current reportApr 17, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedApr 16, 2025Big-stake noticeSEC
UPLOAD · Letter from the SECApr 15, 2025Other filingsSEC
CORRESP · Letter to the SECApr 3, 2025Other filingsSEC
UPLOAD · Letter from the SECApr 1, 2025Other filingsSEC
CORRESP · Letter to the SECMar 27, 2025Other filingsSEC
UPLOAD · Letter from the SECMar 26, 2025Other filingsSEC
DMar 19, 2025Other filingsSEC
8-K · Current reportMar 19, 2025Current reportSEC
PRE 14A · Preliminary proxy statementMar 14, 2025Meeting noticeSEC
8-K · Current reportMar 13, 2025Material contractSEC
4 · Change in ownershipFeb 27, 2025Insider tradeSEC
4 · Change in ownershipFeb 27, 2025Insider tradeSEC
4 · Change in ownershipFeb 27, 2025Insider tradeSEC
4 · Change in ownershipFeb 27, 2025Insider tradeSEC
4 · Change in ownershipFeb 27, 2025Insider tradeSEC
4 · Change in ownershipFeb 27, 2025Insider tradeSEC
4 · Change in ownershipFeb 27, 2025Insider tradeSEC
3 · Initial statement of ownershipFeb 18, 2025Insider tradeSEC
SCHEDULE 13D · Big-stake noticeFeb 12, 2025Big-stake noticeSEC
10-Q · Quarterly reportFeb 11, 2025Quarterly reportSEC
8-K · Current reportFeb 6, 2025Material contractSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 4, 2025Big-stake noticeSEC
8-K · Current reportJan 29, 2025Material contractSEC
8-K · Current reportJan 21, 2025Current reportSEC
8-K · Current reportNov 27, 2024Current reportSEC
10-Q · Quarterly reportNov 12, 2024Quarterly reportSEC
8-K · Current reportOct 1, 2024Current reportSEC
3 · Initial statement of ownershipSep 30, 2024Insider tradeSEC
4 · Change in ownershipSep 20, 2024Insider tradeSEC
4 · Change in ownershipSep 20, 2024Insider tradeSEC
10-K · Annual reportSep 18, 2024Annual reportSEC
8-K · Current reportJul 23, 2024Current reportSEC
8-K · Current reportJul 8, 2024Current reportSEC
8-K · Current reportJul 2, 2024Management or board changeSEC
8-K · Current reportJun 26, 2024Meeting outcomeSEC
8-K · Current reportJun 18, 2024Material contractSEC
8-K · Current reportMay 31, 2024Current reportSEC
S-8 · Registration statement for employee plansMay 9, 2024Offer documentSEC
S-8 · Registration statement for employee plansMay 9, 2024Offer documentSEC
10-Q · Quarterly reportMay 9, 2024Quarterly reportSEC
ARS · Annual report to shareholdersMay 1, 2024Annual reportSEC
DEF 14A · Proxy statementMay 1, 2024Meeting noticeSEC
8-K · Current reportApr 17, 2024Current reportSEC
8-K · Current reportApr 1, 2024Current reportSEC
SCHEDULE 13G · Big-stake noticeFeb 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2024Big-stake noticeSEC
424B5 · ProspectusFeb 13, 2024Offer documentSEC
8-K · Current reportFeb 13, 2024Material contractSEC
10-Q · Quarterly reportFeb 12, 2024Quarterly reportSEC
SC 13G/A · Big-stake notice, amendedFeb 1, 2024Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeJan 26, 2024Big-stake noticeSEC
4 · Change in ownershipJan 25, 2024Insider tradeSEC
4 · Change in ownershipJan 25, 2024Insider tradeSEC
4 · Change in ownershipJan 25, 2024Insider tradeSEC
4 · Change in ownershipJan 25, 2024Insider tradeSEC
4 · Change in ownershipJan 25, 2024Insider tradeSEC
4 · Change in ownershipJan 25, 2024Insider tradeSEC
4 · Change in ownershipJan 25, 2024Insider tradeSEC
8-K · Current reportJan 24, 2024Current reportSEC
8-K · Current reportJan 8, 2024Current reportSEC
10-Q · Quarterly reportNov 13, 2023Quarterly reportSEC
8-K · Current reportOct 19, 2023Current reportSEC
EFFECT · Notice that a registration is effectiveSep 22, 2023Other filingsSEC
CORRESP · Letter to the SECSep 19, 2023Other filingsSEC
SC 13G/A · Big-stake notice, amendedSep 15, 2023Big-stake noticeSEC
S-3/A · Registration statement, amendedSep 12, 2023Offer documentSEC
10-K · Annual reportSep 12, 2023Annual reportSEC
UPLOAD · Letter from the SECJul 25, 2023Other filingsSEC
S-3 · Registration statementJul 20, 2023Offer documentSEC
4 · Change in ownershipJul 13, 2023Insider tradeSEC
3 · Initial statement of ownershipJul 13, 2023Insider tradeSEC
8-K · Current reportJul 13, 2023Management or board changeSEC
8-K · Current reportJul 11, 2023Current reportSEC
EFFECT · Notice that a registration is effectiveJun 9, 2023Other filingsSEC
CORRESP · Letter to the SECJun 6, 2023Other filingsSEC
UPLOAD · Letter from the SECJun 5, 2023Other filingsSEC
S-3 · Registration statementJun 1, 2023Offer documentSEC
10-Q · Quarterly reportMay 9, 2023Quarterly reportSEC
8-K · Current reportApr 27, 2023Meeting outcomeSEC
8-K · Current reportApr 25, 2023Current reportSEC
ARS · Annual report to shareholdersFeb 27, 2023Annual reportSEC
DEF 14A · Proxy statementFeb 27, 2023Meeting noticeSEC
PRE 14A · Preliminary proxy statementFeb 16, 2023Meeting noticeSEC
SC 13G · Big-stake noticeFeb 16, 2023Big-stake noticeSEC
8-K/A · Current report, amendedFeb 14, 2023Current reportSEC
S-8 · Registration statement for employee plansFeb 13, 2023Offer documentSEC
S-8 · Registration statement for employee plansFeb 13, 2023Offer documentSEC
10-Q · Quarterly reportFeb 13, 2023Quarterly reportSEC
SC 13G/A · Big-stake notice, amendedFeb 6, 2023Big-stake noticeSEC
8-K · Current reportFeb 6, 2023Current reportSEC
8-K · Current reportJan 24, 2023Current reportSEC
SC 13D · Big-stake noticeJan 4, 2023Big-stake noticeSEC
DDec 30, 2022Other filingsSEC
8-K · Current reportDec 28, 2022Current reportSEC
4 · Change in ownershipDec 22, 2022Insider tradeSEC
4 · Change in ownershipDec 22, 2022Insider tradeSEC
8-K · Current reportDec 19, 2022Material contractSEC
10-Q · Quarterly reportNov 10, 2022Quarterly reportSEC
8-K · Current reportOct 13, 2022Current reportSEC
8-K · Current reportSep 29, 2022Current reportSEC
424B5 · ProspectusSep 21, 2022Offer documentSEC
10-K · Annual reportSep 21, 2022Annual reportSEC
8-K · Current reportJul 25, 2022Current reportSEC
8-K · Current reportJul 13, 2022Current reportSEC
8-K · Current reportJun 23, 2022Management or board changeSEC
10-Q · Quarterly reportMay 9, 2022Quarterly reportSEC
DEF 14A · Proxy statementApr 27, 2022Meeting noticeSEC
8-K · Current reportMar 24, 2022Current reportSEC
8-K · Current reportMar 8, 2022Current reportSEC
8-K · Current reportFeb 28, 2022Current reportSEC
4 · Change in ownershipFeb 14, 2022Insider tradeSEC
10-Q · Quarterly reportFeb 7, 2022Quarterly reportSEC
SC 13G · Big-stake noticeJan 26, 2022Big-stake noticeSEC
8-K · Current reportJan 10, 2022Material contractSEC
8-K · Current reportJan 3, 2022Current reportSEC
8-K · Current reportDec 27, 2021Current reportSEC
8-K · Current reportNov 16, 2021Current reportSEC
10-Q · Quarterly reportNov 8, 2021Quarterly reportSEC
10-K · Annual reportSep 13, 2021Annual reportSEC

This page holds 200 of 956 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Pluri Inc.’s releases · as of Aug 27, 2026

Common shares
12,611,335
Fully diluted
12,611,335

Fully diluted

LineShares
Common shares12,611,335

Share count over time

CountShares
Nov 22, 202612,611,335

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Armistice Capital, LLC1.2M9.7%US$1.2MSep 30, 2026
Citadel46,1640.37%US$44,784Sep 30, 2026
Renaissance Technologies16,0560.13%US$16,056Sep 30, 2026
Morgan Stanley2,9820.02%US$2,982Sep 30, 2026
EverSource Wealth Advisors, LLC2,0000.02%US$2,000Sep 30, 2026
UBS504<0.01%US$504Sep 30, 2026
Barclays366<0.01%US$366Sep 30, 2026
SIMA Wealth Partners, LLC350<0.01%US$350Sep 30, 2026
Wells Fargo185<0.01%US$185Sep 30, 2026
JPMorgan125<0.01%US$120Sep 30, 2026
All 18 holders
HolderSharesOf the companyValueAs of
RBC125<0.01%Sep 30, 2026
SBI Securities Co., Ltd.97<0.01%US$97Sep 30, 2026
TD93<0.01%US$96Sep 30, 2026
Activest Wealth Management86<0.01%US$83Sep 30, 2026
Osaic Holdings, Inc.50<0.01%US$50Sep 30, 2026
Winch Advisory Services, LLC26<0.01%US$26Sep 30, 2026
TFC Financial Management, Inc.19<0.01%US$19Sep 30, 2026
IFG Advisory, LLC13<0.01%US$13Sep 30, 2026

Funds

HolderSharesOf the companyValueAs of
Fidelity Nasdaq Composite Index Fund2,7510.02%US$6,382May 31, 2026
Dimensional International Small Cap ETF1<0.01%US$1Jul 31, 2026

Insider trades

TradeTradeSharesPriceValueDate
Manieu Alexandre Weinstein
Director, 10% owner
Buy833,334USD 1.50US$1.25MOct 23, 2026

Big stakes

StakeStakeSharesDateFiling
Alexandre Weinstein38.85%4.56MOct 23, 2026Schedule 13D
Chutzpah Holdings Ltd18.50%2.02MJun 30, 2026Schedule 13D
Armistice Capital, LLC9.99%1.27MSep 30, 2026Schedule 13G
Yaky Yanay6.00%485KApr 27, 2023Schedule 13D
Chen Franco-Yehuda0.51%40,064Apr 27, 2023Schedule 13D

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Chen Franco-Yehuda
Other companies: DarioHealth Corp. (Chief Financial Officer · Since at least May 15, 2025)
Chief Financial Officer · Sep 10, 2020 – Sep 18, 2024 · Past
Mark Germain
Other companies: Scinai Immunotherapeutics Ltd. (Director · Since at least Jan 1, 2023)
Director · Dec 14, 2017 – Sep 10, 2020 · Past
Varda Shalev
Other companies: Teva Pharmaceutical Industries Limited (Director · Since at least Sep 1, 2023)
Director · Jul 15, 2021 – Jul 15, 2021 · Past
Alejandro WeinsteinChairman of the Board, Board Member · Since at least Oct 27, 2026
Alexandre Weinstein ManieuDirector · Since at least Feb 25, 2025
Boaz Gur-LavieChief Financial Officer · Feb 4, 2014 – Jan 8, 2015 · Past
Doron ShorrerBoard Member · Since at least Jan 17, 2006
Efrat KaduriChief Business Development Officer – Pharma · Since at least Nov 5, 2026
Eitan AjchenbaumDirector · Since at least Sep 10, 2025
Erez EgoziChief Financial Officer · Mar 29, 2017 – Dec 19, 2018 · Past
All 28 people
PersonSeat
Hava MeretzkiDirector · Jan 17, 2006 – Dec 19, 2018 · Past
Isaac BraunDirector · Jan 17, 2006 – Sep 10, 2020 · Past
Israel Ben-YoramDirector · Dec 26, 2007 – Apr 8, 2019 · Past
Katty DoweryCEO of CellaV Health & Aesthetics · Since at least Jul 28, 2026
Liat ZaltsChief Financial Officer · Since at least Sep 30, 2024
Lior RavivChief Technology Officer · Since at least Nov 5, 2026
Lorne Kenneth AbonyDirector · Jan 23, 2024 – Jan 23, 2024 · Past
Maital Shemesh-RasmussenBoard Member · Since at least Jan 5, 2021
Nachum RosmanDirector · Oct 9, 2007 – Dec 19, 2018 · Past
Nimrod Bar ZviChief Commercial Officer · Since at least Nov 4, 2026
Nofar Glaich-DabachVP Human Resources · Since at least Nov 5, 2026
Ori ShalemVP Operations and Manufacturing · Since at least Nov 5, 2026
Pinhas Doron BirgerDirector · Jul 15, 2021 – Feb 25, 2025 · Past
Rami LeviBoard Member · Since at least Jan 5, 2021
Shai PinesDirector · Dec 8, 2008 – Dec 21, 2011 · Past
Yaky YanayCEO & President · Since at least Nov 1, 2006
Yossi KeretChief Financial Officer · Jan 17, 2006 – Jan 17, 2006 · Past
Zami AbermanDirector · Since at least Feb 10, 2022

Open People

Log in to ask 6ix AI your own questions about Pluri Inc.